Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA3 | P15088 | 1/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5051308 | 0.87 | CPA3 (0.56) | CPA3FOLH1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL877952 | 0.86 | CYP2D6 (0.48) | CPA3FOLH1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL7608582 | 0.84 | CPA3 (0.50) | CPA3FOLH1ALDH1A1CYP1A2CYP2D6 | |
| Ethylene Glycol SCHEMBL3192561 | 0.81 | CYP2D6 (0.44) | CPA3FOLH1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL27944397 | 0.79 | HDAC3 (0.47) | CPA3ALDH1A1CYP1A2CYP2D6TSHR | |
| SCHEMBL3206596 | 0.78 | ALDH1A1 (0.42) | CPA3FOLH1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL3209366 | 0.78 | ALDH1A1 (0.42) | CPA3FOLH1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL7606567 | 0.78 | CPA3 (0.71) | CPA3FOLH1CYP1A2 | |
| Glycerin SCHEMBL3214162 | 0.77 | ALDH1A1 (0.41) | CPA3FOLH1ALDH1A1CYP1A2CYP2D6 | |
| Glycerin SCHEMBL3213893 | 0.77 | ALDH1A1 (0.41) | CPA3FOLH1ALDH1A1CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6265609-B1 | INHIBIT N-ACETYLATED .ALPHA.-LINKED ACIDIC DIPEPTIDASE (NAALADASE) ENZYME ACTIVITY; IN DRUGS TO TREAT GLUTAMATE ABNORMALITIES; COMPULSIVE DISORDERS AND PROSTATE DISEASES, TO EFFECT NEURONAL ACTIVITIES | GUILFORD PHARMACEUTICALS INC. | 2001-07-24 | — | — | US | claimed |
| US-6458775-B1 | N-ACETYLATED .ALPHA.-LINKED ACIDIC DIPEPTIDASE (NAALADASE) INHIBITORS ENZYME ACTIVITY, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH INHIBITORS, AND METHODS OF THEIR USE TO INHIBIT NAALADASE ENZYME ACTIVITY, THEREBY EFFECTING NEURONAL | GUILFORD PHARMACEUTICAL INC. | 2002-10-01 | — | — | US | disclosed |
| US-6265609-B1 | INHIBIT N-ACETYLATED .ALPHA.-LINKED ACIDIC DIPEPTIDASE (NAALADASE) ENZYME ACTIVITY; IN DRUGS TO TREAT GLUTAMATE ABNORMALITIES; COMPULSIVE DISORDERS AND PROSTATE DISEASES, TO EFFECT NEURONAL ACTIVITIES | GUILFORD PHARMACEUTICALS INC. | 2001-07-24 | — | — | US | disclosed |